Literature DB >> 16956963

Distinct roles of PMCA isoforms in Ca2+ homeostasis of bladder smooth muscle: evidence from PMCA gene-ablated mice.

Li Liu1, Yukisato Ishida, Gbolahan Okunade, Gail J Pyne-Geithman, Gary E Shull, Richard J Paul.   

Abstract

We previously showed that plasma membrane Ca(2+)-ATPase (PMCA) activity accounted for 25-30% of relaxation in bladder smooth muscle (8). Among the four PMCA isoforms only PMCA1 and PMCA4 are expressed in smooth muscle. To address the role of these isoforms, we measured cytosolic Ca(2+) ([Ca(2+)](i)) using fura-PE3 and simultaneously measured contractility in bladder smooth muscle from wild-type (WT), Pmca1(+/-), Pmca4(+/-), Pmca4(-/-), and Pmca1(+/-)Pmca4(-/-) mice. There were no differences in basal [Ca(2+)](i) values between bladder preparations. KCl (80 mM) elicited both larger forces (150-190%) and increases in [Ca(2+)](i) (130-180%) in smooth muscle from Pmca1(+/-) and Pmca1(+/-)Pmca4(-/-) bladders than those in WT or Pmca4(-/-). The responses to carbachol (CCh: 10 muM) were also greater in Pmca1(+/-) (120-150%) than in WT bladders. In contrast, the responses in Pmca4(-/-) and Pmca1(+/-)Pmca4(-/-) bladders to CCh were significantly smaller (40-50%) than WT. The rise in half-times of force and [Ca(2+)](i) increases in response to KCl and CCh, and the concomitant half-times of their decrease upon washout of agonist were prolonged in Pmca4(-/-) (130-190%) and Pmca1(+/-)Pmca4(-/-) (120-250%) bladders, but not in Pmca1(+/-) bladders with respect to WT. Our evidence indicates distinct isoform functions with the PMCA1 isoform involved in overall Ca(2+) clearance, while PMCA4 is essential for the [Ca(2+)](i) increase and contractile response to the CCh receptor-mediated signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956963     DOI: 10.1152/ajpcell.00313.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  6 in total

1.  In vivo epithelial wound repair requires mobilization of endogenous intracellular and extracellular calcium.

Authors:  Eitaro Aihara; Courtney L Hentz; Abraham M Korman; Nicholas P J Perry; Vikram Prasad; Gary E Shull; Marshall H Montrose
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

Review 2.  Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.

Authors:  Emanuel E Strehler
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

3.  Isoform-specific up-regulation of plasma membrane Ca2+ATPase expression during colon and gastric cancer cell differentiation.

Authors:  Polett Ribiczey; Attila Tordai; Hajnalka Andrikovics; Adelaida G Filoteo; John T Penniston; Jocelyne Enouf; Agnes Enyedi; Béla Papp; Tünde Kovács
Journal:  Cell Calcium       Date:  2007-04-11       Impact factor: 6.817

Review 4.  Ca2+ clearance and contractility in vascular smooth muscle: evidence from gene-altered murine models.

Authors:  Brian Oloizia; Richard J Paul
Journal:  J Mol Cell Cardiol       Date:  2008-06-10       Impact factor: 5.000

Review 5.  Caloxins: a novel class of selective plasma membrane Ca2+ pump inhibitors obtained using biotechnology.

Authors:  Magdalena M Szewczyk; Jyoti Pande; Ashok K Grover
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657

6.  Functional effects of caloxin 1c2, a novel engineered selective inhibitor of plasma membrane Ca(2+)-pump isoform 4, on coronary artery.

Authors:  Jyoti Pande; Magdalena M Szewczyk; Iwona Kuszczak; Shawn Grover; E Escher; Ashok K Grover
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.